Synthetic Opioid key responses
- Mapping evidence-based key responses to synthetic opioids and their implementation strategies
- Field-tested Toolkit with seven implementation guides
Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men, Martin et al
Behavioral interventions studies addressing hepatitis C virus reinfection are required, such as the ongoing HCVree trial in Switzerland. Other interventions may include traditional harm reduction interventions, adapted behavioral interventions, and interventions to prevent risk related to substance use with sex.
Training Manual for Treatment Advocates; Hepatitis C Virus & coinfection with HIV, Annette Gaudino, Bryn Gay, and Tim Horn
A primary goal of the Training Manual is to increase advocates’ knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.
Liver or Die: HCV Training for Peer Workers
HCV capacity building training for harm reduction programs and peer workers
Hepatitis B and C testing: Why? Who? How?
This paper aims to stimulate services to engage in HCV and HBV awareness raising and in particular to inform community members, social and health care practitioners about current HBV/HCV testing and diagnosis methods, screening technologies and other aspects around the issue.
Hepatitis C Testing in the Community
This booklet provides a comprehensive overview of HCV testing in the community, looking at benefits, effective models, public health burden, policy and barriers.
Online Peer Support Manual
This website provides access to comprehensive resources for organisations and peer workers. Here you can find information on how to support peer workers from organisations and the peer workers.
Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection
Molecular testing atthe point-of-care may turn outto be game changer for HCVdiagnosis and treatment monitoring, through increased sensitivity, reduced turnaround time, and ease of performance. One such assay GeneXpert® has recently been released. Comparative analysis between performances of GeneXpert® and Abbott HCV-RNA was done
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs. Martinello et al
One challenge to achieving HCV elimination through therapeutic intervention is reinfection. There is concern that HCV reinfection may compromise HCV treatment outcomes in populations with ongoing risk behaviors, with the risk of reinfection cited as a reason for not offering treatment to PWID. This review summarizes the literature regarding reinfection after successful HCV treatment among PWID, discusses strategies to reduce HCV infection and reinfection, and highlights the potential individual- and population-level impact of DAA treatmentscale up on HCV elimination.
Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs. Heimer et al.
Hepatitis C virus could not be recovered from cookers regardless of input syringe type or cooker design. Recovery was higher when comparing detachable needles to fxed needles for residue in input syringes (73.8% vs 0%), flters (15.4% vs 1.4%), and receptive syringes (93.8% vs 45.7%).
